Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to|antibodies

• Unité de recherche: INNOSUISSE
• Numéro de projet: 16312.1 PFLS-LS
• Titre du projet anglais: Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to|antibodies

Description succincte (Allemand)

Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies

Description succincte (Anglais)

Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to|antibodies

Résumé des résultats (Abstract) (Allemand)

Antibody conjugates have recently been proven to be highly potent anti-tumour drugs, exceeding the efficacy of conventional antibodies. There is great commercial interest in|developing site-specific payload conjugation technologies. We have established sortaseenzyme|mediated site-specific toxin conjugation to mAbs with sortase A known in the prior art. We aim to develop novel, patentable sortase variants with improved and altered|specificities for extending the technology and IP base of the commercial partner.

Résumé des résultats (Abstract) (Anglais)

Antibody conjugates have recently been proven to be highly potent anti-tumour drugs, exceeding the efficacy of conventional antibodies. There is great commercial interest in|developing site-specific payload conjugation technologies. We have established sortaseenzyme|mediated site-specific toxin conjugation to mAbs with sortase A known in the prior art. We aim to develop novel, patentable sortase variants with improved and altered|specificities for extending the technology and IP base of the commercial partner.